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TCR sensing of peptide/MHC generates sig-
nals that are translated into biological responses 
as diverse as cell survival, homeostatic prolifera-
tion, clonal deletion or expansion, immune 
memory generation, and tolerance. A molecu-
lar model explaining this functional fl  exibility 
posits that the intensity and duration of pep-
tide/MHC stimuli impact the qualitative and/
or quantitative composition of the TCR-prox-
imal signaling machinery, triggering activation 
of all or part of a complex array of immediate 
signaling pathways (1). This results in diversi-
fi  ed gene expression profi  les, making cells dis-
tinctively receptive to auxiliary environmental 
cues (e.g., cytokines and/or cell–cell interac-
tions) and therefore shapes a particular func-
tional behavior (2, 3).
TCR engagement activates the protein tyro-
sine kinases Lck, Fyn, and ζ chain–associated 
protein of 70 kD that initiate the signaling 
  cascade and contribute to the assembly of a 
“signalosome,” a multiprotein complex includ-
ing various enzymes, their substrates, and scaf-
fold/adaptor proteins (4). A major platform for 
the nucleation of this complex is provided by 
two docking elements, the lipid microdomain-
anchored protein linker for activation of T cells 
(LAT; reference 5) and its cytoplasmic partner 
SH2 domain–containing leukocyte protein of 
76 kD (SLP-76; reference 6), recruited onto 
LAT via the SH2-mediated binding of the 
constitutively associated Grb2-related adaptor 
downstream of Shc (Gads; reference 7). Phos-
phorylation of tyrosines on LAT and SLP-76 
allows recruitment of eff  ectors that channel sig-
nals to downstream pathways. For instance, LAT 
binds phospholipase C (PLC)-γ1 (5), which 
regulates Ca2+- and diacylglycerol-dependent 
events (e.g., activation of the NFAT transcrip-
tion factor and protein kinase C [PKC]), and 
Grb2, which recruits the Ras-specifi  c activator 
SOS or the E3-ubiquitin ligase Casitas B lin-
eage lymphoma proto-oncogene (8). Additional 
SH2 domain binding motifs in the N-terminal 
region of SLP-76, encompassing phosphorylated 
Y113, Y128, and Y145, recruit the adaptor Nck, 
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the guanine-nucleotide exchange factor Vav-1 and the induc-
ible T cell kinase, which regulate actin cytoskeleton reorga-
nization and PLC-γ1 activation (9). Furthermore, SLP-76 
associates through its C-terminal SH2 domain with the 
adhesion- and degranulation-promoting adaptor protein, 
an essential regulator of inside-out integrin signaling, and 
with the hematopoietic progenitor kinase 1 (HPK-1, also 
named mitogen-activated protein kinase kinase kinase kinase 
[MAP4K]1; see below and reference 9).
Assembly of the signalosome relies on networks of co-
operative interactions (10, 11), better suited for precise juxta-
position of its components and global stability. However, this 
protein ensemble remains relatively dynamic. For instance, 
SLP-76 detaches from plasma membrane–proximal protein 
complexes a few minutes after TCR stimulation and translo-
cates to a perinuclear compartment (12). Such architectural 
organization and dynamic behavior likely ensure timely acti-
vation of eff  ectors while providing multiple regulatory check-
points. Several inputs, generated by the TCR as well as by 
other receptors (e.g., CD28; reference 13), are integrated at 
these checkpoints that participate in setting thresholds for sig-
nal initiation and propagation.
Although we mostly appreciate how the TCR signalo-
some works in the “forward” mode toward cellular  activation, 
it is less clear when and how counteracting signals that may 
tune signal kinetics and intensity are elicited. Various TCR-
proximal mechanisms may curtail activation, involving spe-
cifi   c negative adaptors (e.g., PAG/Cbp, Gab-2, and Dok 
proteins; reference 14), protein tyrosine phosphatases (PTPs; 
reference 15), or ubiquitination and degradation of selected 
components (16). More recently, examples of negative regu-
lation by Ser/Thr protein kinases have been described. For 
instance, extracellular signal-regulated kinase (ERK)-dependent 
Thr phosphorylation of LAT interferes with PLC-γ1 recruit-
ment and consequently reduces NFAT transcriptional activ-
ity (17). Moreover, HPK-1 inhibits ERKs and NFAT/AP1 
transcription factors in T cells (18, 19). Although TCR-
dependent tyrosine phosphorylation of HPK-1 and its inter-
action with the SH2 domain of SLP-76 are involved in 
optimal activation of this kinase and consequent inhibition of 
downstream pathways (20), the underlying mechanisms are 
incompletely understood. Thus, unraveling the opposing 
mechanisms that shape the generation and life span of the 
signalosome (e.g., assembly/disassembly) may help us to better 
understand how the TCR sets in motion T cell fate.
Given the central role of SLP-76 within the TCR-
  dependent signalosome, we chose this scaff  old protein as an 
“entry point” for identifying new regulators of T cell activa-
tion. Thus, we surveyed proteins associated to SLP-76 by us-
ing immuno-affi   nity purifi  cation and mass spectrometry (MS). 
Figure 1.  Detection of inducible association of 14-3-3 proteins to 
SLP-76 and serine 376 phosphorylation. (A) WT#27 cells overexpress-
ing FLAG–SLP-76 and parental T8.1 cells were left unstimulated (−) or 
activated by anti-CD3 cross-linking (+) for 5 min at 37°C. Lysates were 
incubated with anti-FLAG affi  nity resin, and bound proteins were eluted 
with an excess of FLAG peptide. Eluates were then fractionated by SDS-
PAGE, and proteins were detected by colloidal blue staining. Relevant 
protein bands were excised, digested in gel by trypins, and identifi  ed by 
MALDI-TOF peptide mass fi  ngerprinting. Migration of protein standards is 
indicated on the left. (B) WT#27 cells were left unstimulated (ctrl), acti-
vated at 37°C by CD3 cross-linking as in A, or treated with 1 μM calyculin 
A (Cal.A), 10 ng/ml PMA, or 1 μM okadaic acid (OA) for 30 min at 37°C. 
Lysates were immunoprecipitated with anti-FLAG antibodies as 
described in A and immunoblotted with anti-FLAG (top) or anti–14-3-3 
(bottom) antibodies. (C) FLAG–SLP-76 was immunoprecipitated from 
CD3 cross-linking–stimulated WT#27 cells as described in A. The protein 
band was excised and digested in gel by trypsin and AspN. The resulting 
peptide mixture was analyzed by nanoESI MS. The acquired MS/MS 
dataset was submitted to sequence tag scanning to spot modifi  ed pep-
tides. The MS/MS spectrum shows fragment ions of a peptide spanning 
residues 376–391 of SLP-76, which clearly demonstrates phosphorylation 
of S376.JEM VOL. 204, March 19, 2007  683
ARTICLE
We found that members of the 14-3-3 protein family bind to 
SLP-76 upon TCR stimulation, although with delayed ki-
netics compared with other previously described SLP-76 
signaling partners. This interaction was induced by the HPK-
1–dependent phosphorylation of S376 of SLP-76. Impairing 
14-3-3 recruitment by mutating S376 resulted in increased 
tyrosine phosphorylation of both SLP-76 and PLC-γ1 and 
improved IL-2 promoter activation.
Thus, our study reveals the mechanism of a novel nega-
tive feedback loop initiated from SLP-76 to modulate signal 
intensity during T cell activation.
RESULTS
Activation-induced association of 14-3-3 proteins 
with serine-phosphorylated SLP-76
To discover new components of the TCR signalosome nucle-
ated around SLP-76, we used a cell line (WT#27) derived 
from the murine T cell hybridoma T8.1, which stably ex-
presses a FLAG–SLP-76 construct (21). SLP-76 and associated 
proteins were isolated by anti-FLAG immuno-affi   nity purifi  -
cation and fractionated by SDS-PAGE. Proteins absent in anti-
FLAG immunoprecipitates from untransfected T8.1 cells or 
whose intensity increased in WT#27 cells after anti-CD3 
stimulation (Fig. 1 A) were identifi  ed by matrix-assisted laser 
desorption and ionization time of fl  ight (MALDI-TOF) pep-
tide mass fi  ngerprinting. In addition to previously described 
SLP-76 binding partners, such as Gads, Grb-2, and adhesion- 
and degranulation-promoting adaptor protein (Fig. 1 A and 
not depicted; reference 9), two members of the 14-3-3 protein 
family, namely the ζ and ε isoforms, were found in FLAG–
SLP-76 immunoprecipitates from stimulated cells (Fig. 1 A). 
This previously unknown interaction was confi  rmed by diff  er-
ent approaches. First, FLAG–SLP-76 immunoprecipitates 
from anti-CD3–stimulated WT#27 cells were probed with 
an anti–pan-14-3-3 antibody, which revealed a protein of 
Mr ≈ 30,000 (Fig. 1 B), the expected size for 14-3-3. Second, 
human and mouse SLP-76 bound to a glutathione-S-transferase 
(GST)–14-3-3ζ fusion protein either in pull-down or Far 
Western assays after anti-CD3 stimulation (not depicted).
In mammals, seven genes encode 14-3-3 protein family 
members, which are ubiquitously expressed as homodimers 
or heterodimers. They are implicated in many cellular pro-
cesses, such as regulation of cell cycle, metabolism, and signal-
ing (22). Hundreds of intracellular proteins, including some 
signaling proteins in T cells (23–26), have been reported to 
interact with 14-3-3 isoforms, and in most cases, 14-3-3s as-
sociate to their partners by binding to specifi  c sequences con-
taining a phosphorylated Ser or Thr residue (22). This also 
appears to be the case for SLP-76 because treatment of cells 
with inhibitors of Ser/Thr phosphatases, i.e., calyculin A and 
okadaic acid, induced the binding of 14-3-3 proteins to SLP-76 
(Fig. 1 B). In contrast, the PKC activator PMA was rather 
ineff  ective at stimulating this interaction (Fig. 1 B). These data 
reveal an interaction between SLP-76 and 14-3-3 proteins 
induced by TCR engagement and suggest that it is mediated 
by inducible Ser/Thr phosphorylation of SLP-76.
Phosphorylation of SLP-76 at serine 376 induces 
the association with 14-3-3 proteins
Although three consensus 14-3-3 binding motifs have been 
described, several unconventional binding motifs have been 
reported as well (for review see reference 22). Thus, we ana-
lyzed FLAG–SLP-76 isolated from resting and stimulated 
Figure 2.  Serine 376 of SLP-76 controls the interaction with 
14-3-3 proteins. (A) COS-7 cells were transfected with a myc–14-3-3ζ–
encoding plasmid together with FLAG–SLP-76 constructs, either WT or Ser 
to Ala mutants. After 36 h, cells were harvested and incubated for 10 min 
at 37°C with medium alone (−) or 1 μM calyculin A (+). Cell lysates were 
subjected to anti-FLAG immunoprecipitation, and bound proteins were 
analyzed by anti-FLAG (top row) and anti–14-3-3ζ immunoblotting (sec-
ond row from top). Protein expression in all samples was assessed by anti-
FLAG and anti–14-3-3ζ immunoblotting on whole cell lysates (two bottom 
rows). (B) J14-derived clones expressing similar amounts of FLAG-SLP-76-
WT (clones C5, D9, and E5) or -S376A (clones E6 and E11) were left un-
stimulated or activated by anti-CD3 cross-linking for 5 min at 37°C. 
Samples were lysed, immunoprecipitated with anti-FLAG antibodies (top 
rows), and subjected to anti-FLAG and 14-3-3ζ immunoblotting. Anti-FLAG 
and anti–14-3-3ζ immunoblots on whole cell lysates (bottom rows) dem-
onstrate comparable expression of transfected SLP-76 constructs and en-
dogenous 14-3-3ζ. (C) J14 cells stably expressing FLAG-SLP-76-WT (clone 
C5) or -S376A (clone F3) were left unstimulated (medium) or treated with 
10 μg/ml anti-CD3 mAb or 1 μM calyculine A (calyc.A) for 5 min at 37°C. 
Lysates were then immunoprecipitated with an anti-FLAG mAb. After SDS-
PAGE and transfer onto nitrocellulose, proteins were denaturated and rena-
turated, and then probed with either GST-P3 (top left row; reference 45) or 
a GST–14-3-3ζ fusion protein (top right row). Specifi  c binding was de-
tected by an anti-GST mAb (top rows). Membranes were then stripped and 
reprobed with an anti–SLP-76 antiserum (M14; bottom rows).684  TUNING OF T CELL ACTIVATION BY SLP-76 AND HPK-1 | Di Bartolo et al.
WT#27 cells by nano-electrospray ionization (nanoESI)-
tandem MS to identify phosphorylated Ser or Thr residues 
potentially involved in 14-3-3 binding. These experiments 
revealed four Ser residues (S130, S207, S376, and S410) that 
were phosphorylated either constitutively or after anti-CD3 
or calyculin A treatment (Fig. 1 C; reference 21). To address 
the implication of these residues in 14-3-3 binding to SLP-76, 
we generated FLAG–SLP-76 mutants bearing Ser to Ala 
mutations at each position. WT or mutant FLAG–SLP-76 
constructs were cotransfected together with 14-3-3ζ into 
COS-7 cells, which were then treated with calyculin A and 
immunoprecipitated by an anti-FLAG antibody. Fig. 2 A 
shows that 14-3-3ζ coprecipitated with WT SLP-76 after ca-
lyculin A treatment, demonstrating that the interaction could 
be reconstituted in this heterologous cell system. Moreover, 
mutation of S130, S207, and S410 only slightly reduced co-
precipitation of the two proteins. Importantly, 14-3-3ζ inter-
action with SLP-76 was undetectable upon mutation of S376, 
suggesting that its phosphorylation is essential for binding.
The critical role of S376 in controlling the 14-3-3–
SLP-76 interaction was further confi  rmed in T cell lines. 
SLP-76–defi  cient J14 cells (27) were reconstituted by trans-
fecting either WT or S376A FLAG–SLP-76. Several stable 
clones expressing similar amounts of tagged SLP-76 proteins 
were selected for further experiments. Fig. 2 B shows that 
endogenous 14-3-3ζ was coprecipitated from clones express-
ing SLP-76–WT after anti-CD3 stimulation, whereas only a 
weak association was observed in unstimulated cells. In con-
trast, induction of 14-3-3ζ binding was severely impaired 
in clones expressing SLP-76–S376A, consistent with S376 
phosphorylation triggering CD3-dependent 14-3-3 binding 
to SLP-76.
To assess whether the interaction between 14-3-3 and 
SLP-76 was direct we used a Far Western assay. SLP-76–WT 
or SLP-76–S376A was purifi  ed by anti-FLAG immuno-
precipitation from J14-derived clones, unstimulated or 
treated with anti-CD3 or calyculin A. As shown in Fig. 2 C, 
no binding of an irrelevant fusion protein, GST-P3, to 
membrane-bound proteins was detected (top left), whereas 
GST–14-3-3ζ specifi   cally bound to SLP-76–WT precipi-
tated from anti-CD3 or calyculin A–treated, but not resting, 
cells (top right, fi  rst three lanes). No binding could be de-
tected on SLP-76–S376A (Fig. 2 C, top right, last three 
lanes), with protein amounts comparable to SLP-76 WT 
(bottom). Collectively, these results demonstrate that T cell 
activation   induces a direct association between 14-3-3ζ and 
SLP-76 that is mediated by a motif encompassing phosphory-
lated S376.
TCR-induced phosphorylation of serine 376 is delayed 
compared with tyrosine phosphorylation of SLP-76
To further characterize S376 phosphorylation, we generated 
a phospho-specifi  c antiserum against a synthetic peptide 
spanning residues 371–380 of human SLP-76 and containing 
phosphorylated S376. Affi   nity-purifi  ed  anti–phospho-S376 
antibody recognized immunoprecipitated SLP-76 only after 
cell treatment by anti-CD3 (Fig. 3 A) or calyculin A (not 
depicted). Using this antibody, we observed that the kinetics 
of S376 phosphorylation coincided with 14-3-3 binding to 
SLP-76 (Fig. 3 A), supporting a causal link between these 
two events. We then compared the kinetics of S376 phos-
phorylation to the phosphorylation of critical tyrosines in the 
N-terminal region of SLP-76. Probing this protein with an 
anti-pY128 mAb demonstrated that in agreement with pre-
vious observations (28), Tyr phosphorylation of SLP-76 was 
rapid and transient, reaching maximal intensity in 2 min or 
less, decreasing after 10 min, and returning to nearly basal 
level by 30 min (Fig. 3 B, top). A mAb against pY113 or 
Figure 3.  Serine 376 phosphorylation is delayed as compared with 
tyrosine phosphorylation of SLP-76. (A) Jurkat cells were left unstimu-
lated (ctrl) or incubated with 10 μg/ml anti-CD3 mAbs for the indicated 
time points. Cells were lysed and immunoprecipitated with an anti–SLP-
76 mAb. Samples were then analyzed by Western blotting with anti-
pS376 (top left) and anti–14-3-3ζ (middle row, left). Membranes were 
then stripped and reprobed with an anti–SLP-76 mAb (bottom row, left). 
Fluorescent immunoblots were acquired and quantifi  ed by using an Odys-
sey scanner. The graph (right) shows the quantifi  cation of band intensities 
in the pS376 (□) and 14-3-3ζ (●) immunoblotting, normalized by the 
amount of immunoprecipitated SLP-76. (B) Jurkat cells were left unstimu-
lated or stimulated by anti-CD3 mAbs as described in A. SLP-76 phos-
phorylation was analyzed by immunoblotting with mAb anti-pY128 (top 
left) and affi  nity-purifi  ed rabbit anti-pS376 antibodies (middle row, left). 
Membranes were then stripped and reprobed with an anti–SLP-76 mAb 
(bottom row, left). Quantifi  cation of anti-pY128 and anti-pS376 and 
  immunoblots, performed as explained in A, is shown on the right. (C) Human 
T cell blasts were stimulated with anti-CD3 mAb for the indicated time 
points. SLP-76 immunoprecipitates were subjected to anti-pY128 (top 
row), anti-pS376 (second row from top), anti–SLP-76 (third row from 
top), and anti–14-3-3ζ (bottom row) immunoblotting.JEM VOL. 204, March 19, 2007  685
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anti-phosphotyrosine mAb gave similar results (not depicted), 
suggesting that all tyrosines of SLP-76 are phosphorylated 
with comparable kinetics. In sharp contrast, S376 phosphory-
lation was relatively weak at 2 min, peaked at  10 min, and 
decreased slowly thereafter, remaining elevated after 1 h (Fig. 
3 B, middle). Phosphorylation of S376 and Y128 upon anti-
CD3 stimulation was also detected in human primary CD4+ 
T cells (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20062066/DC1) and T cell blasts (Fig. 3 C) and 
followed a kinetics similar to that observed in Jurkat cells. 
These diff  erential temporal patterns of Tyr and Ser phos-
phorylation within the same protein suggest a distinct regula-
tory function of these posttranslational modifi  cations in T cell 
activation. It is worth noting that S376 phosphorylation cor-
related with coprecipitation of 14-3-3ζ with SLP-76 in T cell 
blasts (Fig. 3 C), demonstrating that this interaction is also in-
duced in nontransformed lymphocytes.
Mutation of serine 376 correlates with increased activation 
of the IL-2 promoter in T cells
The functional role of S376 phosphorylation was addressed 
by comparing the ability of SLP-76–WT and SLP-76–S376A 
to complement T cell activation in SLP-76–defi  cient  J14 
cells, which fail to induce IL-2 gene transcription (27 and not 
depicted). To avoid discrepancies due to clonal variability 
and protein overexpression, J14 cells were infected with 
retroviral vectors to express SLP-76–WT or SLP-76–S376A 
together with GFP expressed from an internal ribosomal 
entry site. Cells were sorted by FACS to obtain cell popula-
tions (named J14-WT or J14-S376A, respectively) expressing 
comparable amounts of WT and mutant SLP-76, as con-
fi  rmed by immunoblot assay (Fig. 4, A and B). The protein 
expression levels of SLP-76 in these cells closely matched that 
of endogenous SLP-76 in Jurkat cells (Fig. 4 B). J14-WT and 
J14-S376A cells also expressed comparable levels of both 
CD3 and CD28 (Fig. 4 A). An IL-2 promoter–dependent 
luciferase reporter (phIL-2-luc; reference 29) was transiently 
transfected into these cells, which were then treated with ei-
ther medium alone or by anti-CD3 and anti-CD28 anti-
bodies for 6 h. After lysis, luciferase activity was measured in 
protein extracts. Induction of IL-2 promoter–dependent 
transcription by PMA and Ca2+ ionophore, which bypasses 
TCR-proximal signaling, was measured to normalize data for 
transfection effi   ciency. We found that CD3/CD28- stimulated 
IL-2 promoter activation was substantially higher in J14-
S376A than in J14-WT cells (Fig. 4 C), whereas similar 
induction of IL-2 promoter activity was observed when cells 
were stimulated by PMA and Ca2+ ionophore (Fig. 4 D). 
Similar results were also obtained when the phIL-2-luc re-
porter was transiently cotransfected in J14 cells together with 
either SLP-76–WT or SLP-76–S376A expression plasmid 
(not depicted).
Collectively, these data indicate that the S376A muta-
tion unleashes TCR-proximal signaling from a repressive 
  action implicating S376 phosphorylation and 14-3-3 binding 
of SLP-76.
Figure 4.  SLP-76–S376A mutant induces higher IL-2 promoter 
activation and then WT SLP-76. (A) Cells stably expressing FLAG-
SLP-76-WT or -S376A mutant (J14-WT or J14-S376A, respectively) 
were obtained by retroviral infection of J14 cells (see Materials and 
methods). GFP+ cells were then enriched by two round of fl  uorescence-
activated cell sorting to obtain stable cell populations expressing 
comparable levels of GFP (left). Comparable expression of CD3 
(middle) and CD28 (right) by these cells was assessed by fl  ow cytom-
etry using PE-conjugated antibodies. (B) J14, J14-WT, J14-S376A, and 
Jurkat cells were lysed and analyzed by anti–SLP-76 immunoblotting. 
(C) J14-WT and J14-S376A cells were transfected with the phIL-2 
luciferase reporter. 22 h after transfection, cells were incubated for 
6 h with or without increasing amounts of anti-CD3 and 10 μg/ml of 
soluble anti-CD28. Cell lysis and luciferase activity measurement and 
normalization are described in Materials and methods. Each point 
represents average and SD of quadruplicate determination. (D) Aliquot 
of phIL-2 luciferase–transfected J14-WT and J14-S376A cells (see C) 
were stimulated with PMA and the Ca2+ ionophore A23187 to assess 
maximal IL-2 promoter activation. Luciferase induction was measured 
as explained above. Histograms and error bars represent average and 
SD of raw luciferase activity of quadruplicate determinations. RLU, 
relative luciferase units.686  TUNING OF T CELL ACTIVATION BY SLP-76 AND HPK-1 | Di Bartolo et al.
Increased tyrosine phosphorylation of SLP-76 and PLC-𝗄1 
in T cells expressing SLP-76–S376A
To understand how the S376 mutation aff  ects TCR signal 
transduction, we looked for potential modifi  cations in the 
phosphorylation status of critical components of the TCR 
signalosome. As expected, phosphorylation of S376 was de-
tected only in J14-WT, but not in J14-S376A, cells (Fig. 5 A, 
top row). Immunoblotting with anti-pY128 mAb revealed 
that tyrosine phosphorylation of SLP-76 was consistently in-
creased in J14-S376A as compared with J14-WT cells (Fig. 
5 A, second row from top, and B, top). Moreover, tyrosine 
phosphorylation of PLC-γ1 at residue Y783, which is re-
quired for the induction of phospholipase activity (30), was 
found to be increased in J14-S376A cells (Fig. 5 A, third row 
from top, and B, bottom). These results suggest that phos-
phorylation of SLP-76 at S376 and recruitment of 14-3-3 
modulate TCR signaling by aff  ecting tyrosine phosphory-
lation of critical eff  ectors, possibly explaining the increased 
levels of IL-2 gene activation induced by SLP-76–S376A.
The serine/threonine kinase HPK-1 phosphorylates 
serine 376 of SLP-76 and induces the interaction 
with 14-3-3 proteins
We set out to identify the kinase responsible for S376 phos-
phorylation. PKCs, protein kinase A (PKA), and the lipid-
dependent kinase AKT have been all reported to phosphorylate 
14-3-3 binding motifs on diff  erent proteins (22). However, 
using specifi  c pharmacological agonists and antagonists we 
could exclude a role for these kinases in phosphorylating 
SLP-76. For instance, raising cellular cAMP levels by for-
skolin treatment resulted in increased phosphorylation of 
CREB at S133, a specifi  c PKA substrate, without inducing 
S376 phosphorylation (Fig. S2 A, available at http://www
.jem.org/cgi/content/full/jem.20062066/DC1). Moreover, 
PMA treatment of Jurkat T cells, which activates classical and 
novel PKCs, led to robust phosphorylation of ERK kinases 
but did not increase phosphorylation of S376 (Fig. S2 B). Fi-
nally, specifi  c inhibition of anti-CD3–induced PI3K activa-
tion by LY294002 virtually abolished AKT activation but did 
not aff  ect S376 phosphorylation (Fig. S2 C). We then fo-
cused on the Ser/Thr protein kinase HPK-1, which binds to 
the SH2 domain of SLP-76 (20). To address its potential role 
in SLP-76 phosphorylation, we knocked-down HPK-1 ex-
pression by transfection of specifi  c small interfering RNAs 
(siRNAs) into Jurkat cells. As shown in Fig. 6 A (top row), 
transfection of a pool of four siRNAs targeting diff  erent re-
gions of the human HPK1 transcript resulted in a substantial 
decrease ( 80%) in HPK-1 protein expression when com-
pared with control cells electroporated with no siRNA or 
with control siRNAs targeting an unrelated protein. Knock-
down of HPK-1 expression was paralleled by a comparable 
reduction in anti-CD3–induced SLP-76 phosphorylation at 
S376 (Fig. 6 A, second row from top), implicating HPK-1 in 
the induction of S376 phosphorylation. In line with the 
above data obtained with J14-S376A cells, HPK-1 knock-
down and decreased S376 phosphorylation of SLP-76 corre-
lated with signifi  cantly increased tyrosine phosphorylation of 
both SLP-76 and PLC-γ1 (Fig. 6 A, third and fourth row 
from top, respectively). We can exclude that these changes 
resulted from off  -target eff  ects of HPK-1 siRNAs because 
SLP-76 and 14-3-3 expression was not aff  ected by siRNA 
transfection (Fig. 6 A, the two bottom rows), and comparable 
eff  ects on HPK-1 expression and SLP-76 phosphorylation 
were observed upon independent transfections of three dif-
ferent HPK-1–specifi  c siRNA (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20062066/DC1). Im-
portantly, immunoprecipitation of SLP-76 from J14-WT 
cells in which HPK-1 expression was reduced by RNA in-
terference (Fig. 6 B, top row) showed not only considerably 
impaired S376 phosphorylation (Fig. 6 B, fourth row from 
Figure 5.  Increased SLP-76 and PLC-𝗄1 tyrosine phosphorylation 
in T cells expressing the SLP-76–S376A mutant. (A) J14-WT and 
J14-S376A cells were left unstimulated or stimulated by anti-CD3 
mAb for the indicated time points. Lysates were fractionated on 
  NuPAGE gel and immunoblotted with anti–SLP-76 pS376 (top row) 
and pY128 antibodies (second row from top), followed by 
anti–PLC-γ1 pY783 antibodies (third row from top). Equal protein 
  loading in each lane was assessed by 14-3-3ζ immunoblotting (fourth 
row from top). Aliquots of the same lysates were analyzed on a separate 
gel to check for equal amount of SLP-76 constructs in all samples 
(bottom row). (B) Graphs show the comparison of SLP-76 (pY128; top) 
and PLCγ1 (pY783; bottom) phosphorylation in J14-WT (●) versus 
J14-S376A cells (□) after normalization for the amount of 14-3-3ζ 
in each sample.JEM VOL. 204, March 19, 2007  687
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top), but also reduced 14-3-3ζ binding to SLP-76 (Fig. 6 B, 
bottom row), thus formally proving that HPK-1 regulates the 
SLP-76–14-3-3ζ interaction.
The above data did not allow us to distinguish whether 
HPK-1 phosphorylates S376 directly or by recruiting/acti-
vating another kinase. To discriminate between these two 
possibilities, an in vitro kinase assay was set up with WT or 
kinase-defective HPK-1–HA and FLAG–SLP-76 constructs 
isolated separately after transfection of COS-7 cells (see 
Materials and methods). As shown in Fig. 6 C (bottom row), 
a robust phosphorylation of S376 was observed when SLP-76 
was incubated with WT HPK-1 in the presence, but not in 
the absence, of ATP. In contrast, no phosphorylation was 
detected when SLP-76 was mixed with kinase-defective 
HPK-1. These results demonstrate that HPK1 directly phos-
phorylates SLP-76 in vitro and strongly suggest that this is 
also the case in activated T cells.
Collectively, our fi  ndings uncover a novel regulatory 
mechanism that negatively modulates activation-induced tran-
scription in T cells that involves HPK-1–dependent phos-
phorylation of SLP-76 at S376 and recruitment of 14-3-3 
proteins to the TCR-associated signalosome.
DISCUSSION
Current models depicting the TCR signalosome may be 
incomplete because restricted to tyrosine-phosphorylated 
components and to prototypic signaling elements shared by 
many receptors. Thus, novel approaches may be needed to 
probe for yet unknown signaling elements. Moreover, un-
derstanding how TCR signals shape gene activation requires 
evaluating qualitative and quantitative variations within the 
signalosome that are likely to occur as a function of stim-
uli duration and/or intensity. A major hurdle toward these 
goals is that such a protein complex is of low abundance and 
highly dynamic, i.e., intrinsically labile. We tried to over-
come these diffi     culties by combining overexpression of 
  epitope-tagged SLP-76 and its tag-dependent isolation, 
followed by MS identifi  cation of associated proteins. The 
effi   cacy of this approach was demonstrated by the isolation 
of known SLP-76 binding partners and the identifi  cation of 
two novel interacting proteins, both members of the 14-3-3 
protein family. This fi  nding led us to uncover a novel SLP-
76–based negative feedback mechanism that likely serves to 
fi  ne tune TCR-dependent signals.
Association of 14-3-3 proteins with SLP-76 is mediated 
by phosphorylation of S376. This residue, which is part of a 
motif sharing weak homology with the mode I 14-3-3 bind-
ing motif (22), lies in the proline-rich region of SLP-76 that 
mediates association with multiple partners (e.g., Gads, PLC-γ1, 
and inducible T cell kinase). Ser/Thr phosphorylation of 
Figure 6.  HPK-1 phosphorylates SLP-76 at serine 376. (A) Knock-
down of HPK-1 expression in Jurkat T cells was performed by transient 
transfection of synthetic siRNAs. Cells were electroporated in the pres-
ence of medium alone (mock), control siRNAs (ctrl), or HPK-1–specifi  c 
siRNAs (HPK1). After 72 h, cells were left unstimulated or activated by 
anti-CD3 mAb, and lysates were fractionated on Nu-PAGE gels. HPK-1 
expression was assessed by anti–HPK-1 immunoblotting (top row). Phos-
phorylation of SLP-76 and PLC-γ1 was then assessed by immunoblotting 
with anti-pS376 (second row from top), anti-pY128 (third row from top), 
and anti–PLC-γ1 pY783 (fourth row from top). Equal protein loading in 
each lane was demonstrated by anti–SLP-76 and anti–14-3-3ζ immuno-
blotting (two bottom rows). (B) J14-WT cells were transiently transfected 
with either control siRNAs (ctrl) or HPK-1–specifi  c siRNAs (HPK1) as in A. 
After 72 h, cells were left unstimulated or activated by anti-CD3 mAb for 
10 min, and lysates were immunoprecipitated by anti-FLAG antibodies. 
Aliquots of the lysate were analyzed by immunoblotting with anti–HPK-1 
or anti–SLP-76 antibodies (fi  rst and second row from top, respectively). 
Immunoprecipitates were immunoblotted with anti–SLP-76 (third row), 
anti-pS376 (fourth row), and anti–14-3-3ζ (bottom row). Quantifi  cation 
of band intensities and normalization by the amount of SLP-76 in each 
lane indicated that HPK-1 expression, pS376 phosphorylation, and 14-3-3ζ 
binding to SLP-76 were reduced in this experiment by 68, 58, and 50%, 
respectively. (C) COS-7 cells were transfected with FLAG–SLP-76 or HPK-
1–HA constructs, WT, or a kinase-defective mutant (KD). After 36 h, cells 
were harvested, lysed, and immunoprecipitated with anti-FLAG (FLAG–
SLP-76 transfection) or anti-HA antibodies (HPK-1 WT– or KD-transfected 
cells). FLAG–SLP-76 was eluted and mixed with bead-bound HPK-1–WT or 
–KD. Samples were then incubated for 30 min at 37°C in the presence or 
absence of ATP. Protein mixtures were analyzed by immunoblotting with 
anti-FLAG (top row), anti-HA (middle row), and anti-pS376 antibodies 
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SLP-76 has been reported (31), but neither the specifi  c resi-
dues nor the signifi  cance of these modifi  cations was identi-
fi  ed. Our data (see also reference 21) reveal that four Ser 
residues of SLP-76 are phosphorylated either constitutively 
or after cell stimulation, but the role of those residues other 
than S376 remains to be studied. Diff  erent to the immediate 
induction and rapid decrease of phosphorylation of N-terminal 
tyrosines involved in the binding of SLP-76 to other key sig-
naling eff  ectors, S376 phosphorylation peaked at 10–15 min 
and declined slowly, matching the kinetics of 14-3-3 binding. 
These fi  ndings revealed a new mechanism by which SLP-76 
recruits signaling partners and a rapid changing pattern of 
its interactions.
Our results directly implicated HPK-1 in S376 phosphory-
lation. Previously, this kinase was regarded as MAP4K, a 
positive upstream regulator of mitogen-activated protein ki-
nases, such as JNK (32, 33). An implication of HPK-1 in 
TCR-proximal signaling has been suggested (20), but its spe-
cifi  c role in this context has remained elusive. We demon-
strate here that HPK-1 regulates SLP-76, a major TCR 
signaling protein, consistent with previous data showing 
that HPK-1 can inducibly interact with the former (20). We 
cannot exclude that once recruited to SLP-76, HPK-1 might 
also phosphorylate other SLP-76 partners and/or act as a 
MAP4K in T cells.
Data presented herein show that SLP-76 not only orches-
trates positive signaling, but in combination with HPK-1 and 
14-3-3, also generates a delayed negative signal regulating T 
cell activation. Both S376A mutation and HPK-1 knock-
down correlated with increased TCR signal intensity, as 
demonstrated by the augmented tyrosine phosphorylation of 
SLP-76 and PLC-γ1. Reduction of HPK-1 expression by 
siRNA that increases NFAT activity (18) or overexpression 
of this kinase that inhibits ERK and AP-1 activation (19) 
previously suggested that HPK-1 negatively aff  ects TCR-
  induced transcription. During the revision of this article, Shui 
et al. (34) have reported a study of HPK-1–defi  cient mice 
confi  rming the role of HPK-1 as a negative regulator of T 
cell activation and immune response. Similar to our data, 
HPK-1 defi  ciency results in increased TCR-induced tyro-
sine phosphorylation of several signaling proteins, including 
SLP-76 and PLC-γ1, that correlates with increased calcium 
mobilization, ERK activation, and enhanced T cell activa-
tion. Shui et al. also showed that HPK-1 phosphorylates 
SLP-76 in vitro and that SLP-76 associates with 14–3-3τ. We 
have detected 14-3-3ζ, 14-3-3ε (this work), and 14-3-3γ 
(unpublished data) associated with SLP-76 but not 14-3-3τ. 
The reason for this discrepancy is unclear, but it may be due 
to diff  erences in the cells used. These results essentially cor-
roborate our model of negative regulation of T cell activa-
tion through SLP-76, HPK-1, and 14-3-3. However, our 
fi  ndings that mutation of S376, a specifi  c target of HPK-1 
on SLP-76, abolished 14-3-3 binding and resulted in higher 
TCR-dependent IL-2 promoter induction demonstrate 
that 14-3-3 recruitment to SLP-76 is one of the main mech-
anisms by which HPK-1 negatively aff  ects T cell activation. 
Finally, although Shui et al. proposed that S207 of SLP-76 
may be a docking site for 14-3-3, based on conjectures 
about 14-3-3 consensus binding sites (34), our work indi-
cates that S207 does not play a major role in the 14-3-3–SLP-
76 interaction (see Fig. 2). Future studies of knock-in mice 
expressing SLP-76–S376A would address more precisely 
T cell abnormalities in the absence of the signal-modulating 
mechanism describ0ed herein because potential compensa-
tory eff  ects of HPK-1 on other pathways (e.g., JNK) would 
be avoided.
The 14-3-3ζ and τ isoforms have been implicated in neg-
ative regulation of T cell signaling through their interaction 
with Casitas B lineage lymphoma proto-oncogene, PKCθ, 
PI3K, or the adaptor 3BP2 (23–26). Hence, 14-3-3 proteins 
appear to exert a complex control on TCR signaling, relying 
on multiple mechanisms. The mechanism by which S376 
phosphorylation and 14-3-3 recruitment reduces Tyr phos-
phorylation of SLP-76 and PLC-γ1 (and perhaps other part-
ners) is unknown. 14-3-3 binding may disrupt the interaction 
of SLP-76 and its partners with an upstream protein tyrosine 
kinase (e.g., ζ chain–associated protein of 70 kD), thus short-
ening the duration of tyrosine phosphorylation. Other pro-
teins binding to the proline-rich region of SLP-76 (which 
contains the 14-3-3 binding site), might be released upon 
14-3-3 recruitment. However, Gads association with SLP-76 
does not seem to be modifi  ed by 14-3-3 binding because the 
S376A mutation does not aff  ect the Gads–SLP-76 complex 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20062066/DC1). Nonetheless, 14-3-3 proteins could 
compete with the binding of PLC-γ1 or inducible T cell 
  kinase. Alternatively, 14-3-3 proteins may recruit/stabilize 
a PTP in the signalosome or induce dissociation of one or 
more proteins from the complex, leading to increased avail-
ability of phosphorylation sites to PTPs. Another intriguing 
possibility, not mutually exclusive of the above mechanisms, is 
suggested by the role of 14-3-3 proteins as regulators of traf-
fi   cking and subcellular localization of their partners (35). 
Upon 14-3-3 binding, SLP-76 might be released from the 
membrane-proximal signalosome, alone or together with 
some associated proteins, and translocate to a diff  erent intra-
cellular site, as suggested by data reporting a relocation of 
SLP-76 to a perinuclear compartment a few minutes after re-
ceptor engagement (12). Hence, the long-lasting phosphory-
lation of S376 and 14-3-3 binding might also aff  ect potential 
late functions that SLP-76 would exert after leaving the 
membrane-proximal signalosome.
An instructive example of signal down-regulation via an 
adaptor is provided by insulin receptor substrate (IRS)-1, a 
central eff   ector downstream of insulin receptor. Ser/Thr 
phosphorylation of IRS-1 counteracts its tyrosine phosphory-
lation, leading to termination of signaling in a physiological 
setting or to insulin resistance. Impairment of tyrosine phos-
phorylation of IRS-1, dissociation of the latter from the re-
ceptors and from the signaling complex, or its degradation 
has been proposed to explain this negative regulation (for re-
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Ser-phosphorylated IRS-1 and regulate its function (37, 38). 
It is therefore tempting to speculate that the negative feed-
back loop by which SLP-76 contributes to TCR signal 
down-modulation occurs via one of the mechanisms de-
scribed for IRS-1.
We would like to suggest that negative feedback loops 
such as the one described herein, acting so early on antigen 
receptor signals, are not required to stop the signal but rather 
to shape its intensity and/or duration. Indeed, in a physio-
logical setting, T cells collect inputs from peptide/MHC over 
long periods of time and tuning mechanisms may be neces-
sary to funnel the signal within a certain range of intensity and 
duration to orchestrate ordered and dosed gene expression.
Here, we have provided an example of how expressing 
an epitope-tagged central eff  ector coupled to MS analysis can 
uncover previously hidden aspects of TCR signaling. Recent 
advances in sensitivity, mass accuracy, and resolution in MS 
combined with improvements in the isolation of unstable 
protein complexes should reveal further intricacies in the 
molecular mechanisms of T cell activation.
MATERIALS AND METHODS
Antibodies. The following polyclonal antibodies were used: rabbit anti-
body against all 14-3-3 isoforms (Upstate Biotechnology) or specifi  c for 
14-3-3ζ (Santa Cruz Biotechnology, Inc.); goat anti–HPK-1 (Santa Cruz 
Biotechnology, Inc.); rabbit antiserum anti–SLP-76 (M14; reference 39); 
and rabbit antibody against phosphorylated S376 of SLP-76, generated and 
purifi  ed by Eurogentec using the peptide CFPQSA-pS376-LPPY as immuno-
gen. Specifi  c antibodies were purifi  ed onto a phosphopeptide affi   nity column 
and depleted of antibodies recognizing the unphosphorylated peptide. 
Phospho-specifi  c antibodies against PLC-γ1 (pY783; Cell Signaling Tech-
nology) were used. The following mAbs were used: anti-FLAG M2 and 
anti-GST (Sigma-Aldrich); anti–SLP-76 (SLP-76/03) and anti–human CD3 
(UCHT1; Serotec); anti-HA (F7; Santa Cruz Biotechnology, Inc.); anti-
phosphorylated SLP-76 Y113 and Y128 (BD Biosciences); anti-CD28 
(CD28.2; Immunotech); and anti–mouse CD3 (145-2C11; reference 40). 
Phycoerythrin-labeled anti–human CD3 (clone SK7; BD Biosciences) and 
anti-CD28 (CD28.2; eBiosciences) were used for fl  ow cytometry.
Vectors. The pEF-FLAG-SLP-76-WT plasmid (41), coding for the FLAG-
tagged, WT human SLP-76 cDNA, was provided by G. Koretzky (Univer-
sity of Pennsylvania, Philadelphia, PA). Point mutations were introduced by 
using the QuikChange kit (Stratagene). The pCDNA3.1 vector coding 
for MYC-14-3-3ζ was provided by A.S. Shaw (Washington University, 
St. Louis, MO). The GST-14-3-3ζ coding vector was provided by Y.C. Liu 
(La Jolla Institute for Allergy and Immunology, San Diego, CA). GST fusion 
proteins were affi   nity  purifi   ed on Gluthatione-Sepharose 4B resin (GE 
Healthcare). Retroviral vectors were prepared as described previously (42) 
by fi  rst introducing FLAG-SLP-76-WT or FLAG-SLP-76-S376A cDNA in 
the pDONR221 donor plasmid (Invitrogen), and then transferring it into 
the Gateway A-pMX-IRES-GFP vector (provided by S. Constantinescu, 
Ludwig Institute for Cancer Research, Brussels, Belgium; reference 42). The 
resulting pMX-WT-IRES-GFP and pMX-S376A-IRES-GFP vectors were 
transduced in J14 cells.
The pMT2-HPK-HA and pMT2-HPK(K46E)-HA vectors (33), cod-
ing for HA-tagged WT or kinase-defi  cient HPK-1 proteins, respectively, 
were provided by F. Kiefer (Max Planck Institute for Molecular Biomedi-
cine, Münster, Germany).
Cell lines, transfection, and retroviral infection. Jurkat E6.1 (referred 
to as Jurkat) and J14 cells (provided by A. Weiss, University of California, 
San Francisco, San Francisco, CA) were cultured as described previously (27). 
The murine T cell hybridoma T8.1 and the WT#27 clone overexpressing 
FLAG-SLP-76-WT were generated and maintained as described previously 
(21). J14-derived cells stably expressing SLP-76 constructs were obtained by 
cotransfecting 20 μg pEF-FLAG-SLP-76 plasmid, either -WT or -S376A, 
and 20 μg pSRα-puromycin vector as described previously (43). J14-
derived cell populations stably expressing FLAG-SLP-76-WT or -S376 
(named J14-WT and J14-S376A, respectively) were obtained as follows. Viral 
particles were produced by cotransfection of 293T cells with an encapsida-
tion plasmid (pCMV-MLVgagpol; provided by D. Bohl, Institut Pasteur), 
the pHCMV-G plasmid coding for VSV-G envelope glycoprotein, and ei-
ther pMX-WT-IRES-GFP or pMX-S376A-IRES-GFP. Viruses were con-
centrated from culture supernatants and used to infect J14 cells by two 
rounds of spinoculation (2,500 rpm for 1 h 30 min at 30°C) in the presence 
of 8 μg/ml polybrene. GFP+ cells were then enriched by fl  uorescence-
activated cell sorting. COS-7 cells were maintained and transfected as 
described previously (44). T cell blasts were prepared from human PBMCs 
as described previously (45).
MS analysis. To identify SLP-76 associated proteins, anti-FLAG immuno-
precipitates from WT#27 cells were eluted with FLAG peptide, fraction-
ated by SDS-PAGE, and stained by colloidal blue (Invitrogen). Relevant 
bands were excised and digested in gel by trypsin (46), and proteins were 
identifi  ed by MALDI-TOF MS at the proteomic facility of the Institut 
Pasteur. For the identifi   cation of SLP-76 serine phosphorylation sites, 
  immunoprecipitated FLAG–SLP-76 isolated from stimulated WT#27 cells 
was digested in gel (46) by using a combination of trypsin and AspN in 
a 1:1 ratio. Mass spectra acquisition by nanoESI-tandem MS and analysis 
and data fi  ltering by sequence tag scanning were performed as described 
previously (21).
IL-2 promoter activity assays. J14-WT and J14-S376A cells were tran-
siently transfected by electroporation at 260 V, 950 μF, with 5 μg of the 
phIL-2 luciferase reporter plasmid (provided by J.F. Peyron, Université de 
Nice-Sophia Antipolis, France). Total DNA amount was raised to 30 μg us-
ing an empty pEF-Bos vector. 22 h later, cells were left unstimulated or 
stimulated either with increasing concentrations of plate-bound anti-CD3 
(30–150 ng/ml) plus 10 μg/ml of soluble anti-CD28 or a combination of 
10 ng/ml PMA (Sigma-Aldrich) and 250 ng/ml of the calcium ionophore 
A23187 (Calbiochem) in 96-well plates. After 6 h, cells lysis and luciferase 
activity assays were performed as described previously (29). Percent lucifer-
ase activity for anti-CD3/CD28–stimulated samples was calculated as fol-
lows: % = ((RLU-MIN)/(MAX-MIN))×100, where RLU is the measured 
luciferase activity of the sample, MIN is the average RLU for the unstimu-
lated sample, and MAX is the average RLU for sample stimulated with 
PMA/A23187.
siRNA transfection. All siRNA duplexes were purchased from Dharma-
con Inc. HPK-1 knock-down was obtained by electroporating cells at 300 V, 
500 μF essentially as described above in the presence of 400 nM of the 
MAP4K1 siGENOME SMARTpool. Control cells were electroporated 
without siRNA or with a pool of unrelated siRNAs (siCONTROL non-
targeting siRNA pool). Knock-down effi   ciency assessment and cell analysis 
were performed 72 h after transfection.
Immunoprecipitation, immunoblotting, and Far Western assay. 
Immunoprecipitations were performed as described previously (29). Protein 
electrophoresis was performed on standard SDS-PAGE or NuPAGE gels 
(Invitrogen). Immunoblots were detected by either enhanced chemilumi-
nescence or by near-infrared fl  uorescence. In the latter case, secondary anti-
bodies labeled with either AlexaFluor 680 (Invitrogen) or IRDye 800 
(Rockland Immunochemicals) were used. Fluorescent immunoblot images 
were acquired and quantifi  ed by using an Odyssey scanner and the Odyssey 
1.2 software (Li-Cor Biosciences). Far Western assays were performed 
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In vitro phosphorylation assay. COS-7 cells transfected with pEF-
FLAG-SLP-76-WT or pMT2-HPK-HA or pMT2-HPK(K46E)-HA were 
immunoprecipitated with anti-FLAG or anti-HA antibodies, respectively. 
FLAG-SLP-76-WT was eluted by incubating beads with 0.4 mg/ml FLAG 
peptide and mixed with either HPK-1 construct in 50 mM Tris-HCl, pH7.4, 
10 mM MgCl2, 1 mM EDTA, and 0.1% NP-40 with or without 40 μM 
ATP. Reaction mixtures were incubated at 30°C for 30 min and analyzed by 
  immunoblotting to detect S376 phosphorylation and protein amounts.
Online supplemental material. Fig. S1 shows that phosphorylation of 
SLP-76 in primary CD4+ T cells follows the same kinetics observed in   Jurkat 
cells and human T cell blasts (see Fig. 3). Data in Fig. S2 demonstrate that 
PKA, PKC, and AKT kinases are not involved in the phosphorylation of 
S376 of SLP-76. Data shown in Fig. S3 rule out that the eff  ects of HPK-
1–specifi  c siRNAs are due to off  -target eff  ects. Fig. S4 shows that mutation 
of S376 of SLP-76 strongly impairs the binding of this protein to 14-3-3ζ 
(  bottom) but does not aff  ect the constitutive interaction between Gads 
and SLP-76(middle). Figs. S1–S4 are available at http://www.jem.org/
cgi/content/full/jem.20062066/DC1.
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